Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1991
Prion diseases in manF Jacob, F Ries, M Dicato
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|December 2, 2000
Complications and hospitalisation--duration after chemoembolisation for liver metastasesS Rauh, C Duhem, F Ries, et al.
Seminars in Oncology|November 28, 1997
Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancerF Ries, C Duhem, K Kleiber, et al.
Cytokines, Cellular & Molecular Therapy|June 1, 1997
Multidrug resistance: molecular and clinical aspectsM Dicato, C Duhem, M Pauly, et al.
Current Opinion in Oncology|July 11, 2000
Clinical benefit from erythropoietinM Dicato, C Duhem, G Berchem, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1990
Camembert, Listeria and the immunocompromised patientF Ries, M Dicato, R Hemmer, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg|January 1, 1997
[New diagnostic approaches to deep venous thrombosis]S Rauh, M Dicato, C Duhem, et al.
Pathologie-Biologie|June 1, 1982
[Salmonella dublin enteric fever in two compromised hosts]R J Hemmer, F Schneider, M Dicato, et al.
The Journal of Allergy and Clinical Immunology|November 1, 1986
Acquired C1 esterase-inhibitor deficiency: case report with emphasis on complement and kallikrein activation during two patterns of clinical manifestationsF Hentges, R Humbel, M Dicato, et al.
Biochemical Pharmacology|July 26, 2011
Erythropoietin, erythropoiesis and beyondS Chateauvieux, C Grigorakaki, F Morceau, et al.
Pageof 7